Atomo Diagnostics Ltd (AT1) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return


Atomo Diagnostics Ltd Chart

Share price
Last
Change
Volume
Turnover
Market Cap $127.9 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

AT1 Statistics

23 October

770 / 2,222

ASX Size Rank

1yr Return

vs Sector (1yr)

-35.69%

vs ASX 200 (1yr)

-11.36%

$127.9 million

Market Cap

Share Issue

406.04 million

All Ords (%)

0.01%

Short Sold

0.76%

Current Fundamentals

23 October

N/A

PE Ratio

EPS ($)

-

Earnings Yield

-

NTA ($)

-

0.00%

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Atomo Diagnostics Limited (AT1) is a medical device company and is establishing an in-house assembly and packing facility in South Africa and has a commercial office in the UK. Its Rapid Diagnostic Test devices are used both by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection.

Atomo Diagnostics Ltd Logo

Corporate Details

Head Office: Leichhardt
Managing Director: John Kelly
GICS Sub-Industry: Health Care Equipment
Date Listed: 16 Apr 2020
Registry: -
Similar Companies: FPH / COH / RMD / ANN / NAN

Upcoming Calendar

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Announcements provided by

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

AT1 is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data


Name Title Since Bio
Dr Paul Alexander Kasian Non-Executive Director -
Ms Constance (Connie) Bernadette Carnabuci Non-Executive Director Feb 2020
Mr John Perry Keith Non-Executive Chairman, Non-Executive Director Dec 2011
Mr John Michael Kelly Founder, Managing Director Apr 2010
Dr Curt Harold LaBelle Non-Executive Director Oct 2016
Fabio Baglioni Chief Commercial Officer N/A
William Souter Chief Financial Officer N/A
Mark Smith Chief Operating Officer N/A
Gillian Maria Nairn Company Secretary N/A

Director Transactions

About the Data

AT1 directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code AT1 in our database.

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 403 4,087 1,488 2,501 314 8,793

Top 20 Shareholders

About the Data

Name Shares Capital
Dalraida Holdings Pty Limited 66,160,000 11.79%
Global Health Investment Fund I Llc 63,851,280 11.38%
Walker Group Holdings Pty Ltd 46,660,718 8.32%
National Nominees Limited 32,478,361 5.79%
J P Morgan Nominees Australia Pty Limited 18,556,834 3.31%
HSBC Custody Nominees (Australia) Limited 17,624,130 3.14%
Blueflag Holdings Pty Ltd 13,760,000 2.45%
Grand Challenges Canada 11,390,824 2.03%
Liverbird Pty Ltd 9,731,653 1.73%
Sokolov Pty Ltd 9,202,181 1.64%
I D E Pty Ltd 9,032,248 1.61%
Mark Andrew Smith 7,790,224 1.39%
John Michael Kelly 7,370,248 1.31%
Leo James Lynch & Judith Anne Beswick 7,321,121 1.30%
Bnp Paribas Noms Pty Ltd 6,972,741 1.24%
Hsbc Custody Nominees (Australia) Limited A/C 2 6,528,750 1.16%
Mr Ian Fredrick Johnson 6,079,560 1.08%
Bosana Nominees Pty Ltd 5,881,496 1.05%
Ruth Karen Devney 5,626,408 1.00%
Nicola Jayne Rigby 4,846,220 0.86%
All other shareholders 36.42 %


The Top 20 Shareholders of AT1 hold 63.58% of shares on issue.

AT1 Share Price History

Date Close Change % Change Open High Low Volume Turnover

AT1 Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade
2020 $0.34 30 June

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Development and sale of medical devices.

Incorporated: --

Level 2, 701-703 Parramatta Rd
Leichhardt NSW 2040


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.